Cancer Immunity

1Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tumors are highly complex tissues consisting, beside the transformed cells, of various non-transformed cells including immune cells. Tumor-associated immunity has been a major focus of research in oncology recently due to the now widely accepted notion that immunity critically shapes tumor development. While chronic inflammation can favor tumorigenesis largely by promoting cellular transformation, immune cells can recognize cancer cells as altered-self and eliminate them. However, tumors that have escaped immune attack have found ways to educated immune cells to actively support tumor development. We summarize the multifactorial of immunity with transformed cells, focusing on the key elements involved in the generation of antitumor responses: the cellular and molecular components of the immune system. On this basis, we discuss the current efforts to develop immunotherapeutic approaches with the goal to fight cancer, and delineate future challenges in anti-cancer immunotherapy.

Cite

CITATION STYLE

APA

Mora, J., Alpízar-Alpízar, W., & Weigert, A. (2019). Cancer Immunity. In Nijkamp and Parnham’s Principles of Immunopharmacology: Fourth revised and extended edition (pp. 191–208). Springer International Publishing. https://doi.org/10.1007/978-3-030-10811-3_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free